October 20, 2016 4:41 PM ET

Life Sciences Tools and Services

Company Overview of Yumanity Therapeutics Inc.

Executive Profile

N. Anthony Coles M.D., M.P.H.

Chairman and Chief Executive Officer, Yumanity Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 8 Board Members in 8 different organizations across 11 different industries.

See Board Relationships


Dr. N. Anthony Coles, also known as Tony, M.D., M.P.H., serves as the Chief Executive Officer and Founding Investor of Yumanity Therapeutics, Inc. Dr. Coles serves as Chief Executive Officer of TRATE Enterprises, LLC. Dr. Coles served as President and Chief Executive Officer at Onyx Pharmaceuticals, Inc. since December 17, 2012, 2012 and March 31, 2008 respectively. Dr. Coles served as the President of Onyx Pharmaceuticals, Inc. since March 31, 2008. Prior to joining ...

Corporate Headquarters

790 Memorial Drive
Cambridge, Massachusetts 02139

United States

Phone: 617-409-5300
Fax: --

Board Members Memberships

Chairman and Chief Executive Officer
Director, Chairman of Finance Committee and Member of Compensation Committee
Independent Director
Chairman of the Board and Member of Compensation, Nomination & Corporate Governance Committee


Master's Degree
Harvard University
Duke University
Johns Hopkins University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Yumanity Therapeutics Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.